/Investor DB

redalpine — 2019 Investments

4 investments dated 2019 · listed companies and verified rows first · show all

Bnextbnext.bioOct 2019 · $25M

b.next develops technologies and infrastructure for building synthetic cells from scratch, working with researchers, universities, governments, and funders.

BiotechDeep Tech

Akshay Maheshwari, MD, PhD(Founder)in

Co-investorsFifty YearsCometaConexo VenturesDN CapitalEnernFounders Future+2 more

Bnextbnext.com.twOct 2019 · $25M

Business Next (數位時代) is a Taiwanese digital news and media outlet covering technology, startups, AI, e-commerce, and business trends.

Media & Entertainment

Co-investorsAVA AngelsCometaConexo VenturesDN CapitalEnernFounders Future+2 more

Lengoolengoo.cominSep 2019Defunct

Lengoo was a Berlin-based B2B startup offering AI-powered machine translation software that trained custom models on each enterprise client's own language data, combined with professional human linguists.

Berlin, DE

Co-investorsCreathor VenturesHOWZAT PartnersInkefPolipo VenturesRheingau FoundersTechstars+1 more

Versantisversantis.cominSep 2019acquired by GENFIT

GENFIT is a biopharmaceutical company developing therapies for rare, life-threatening liver diseases, with a focus on acute-on-chronic liver failure (ACLF), hepatic encephalopathy (HE), cholangiocarcinoma, urea cycle disorders, and organic acidemias.

BiotechDigital HealthMedical Devices

Co-investorsOCCIDENTVerve VenturesEsperante VenturesHealthequity

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.